MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.
暂无分享,去创建一个
Nathalie Wong | N. Wong | P. Lai | K. To | K. Chan | Ka-Fai To | Queenie W-L Wong | Raymond W-M Lung | Priscilla T-Y Law | Paul B-S Lai | Kathy Y-Y Chan | Priscilla T. Y. Law | Q. Wong | R. W. Lung
[1] P. Schirmacher,et al. Protumorigenic overexpression of stathmin/Op18 by gain‐of‐function mutation in p53 in human hepatocarcinogenesis , 2007, Hepatology.
[2] K. Hruska,et al. MicroRNA‐223 is a key factor in osteoclast differentiation , 2007, Journal of cellular biochemistry.
[3] L. Fazli,et al. Increased expression and differential phosphorylation of stathmin may promote prostate cancer progression , 2007, The Prostate.
[4] C. Croce,et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. , 2007, Cancer research.
[5] Yoko Fukuda,et al. An Evolutionarily Conserved Mechanism for MicroRNA-223 Expression Revealed by MicroRNA Gene Profiling , 2007, Cell.
[6] W. Hait,et al. Reversal of Stathmin-Mediated Resistance to Paclitaxel and Vinblastine in Human Breast Carcinoma Cells , 2007, Molecular Pharmacology.
[7] M. Ringnér,et al. Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity , 2007, Proceedings of the National Academy of Sciences.
[8] Michael T. McManus,et al. Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2 , 2007, Cell.
[9] S. Franceschi,et al. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review , 2007, British Journal of Cancer.
[10] George A Calin,et al. Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas , 2007, Journal of cellular physiology.
[11] Thomas D. Schmittgen,et al. Expression profiling identifies microRNA signature in pancreatic cancer , 2006, International journal of cancer.
[12] Z. Goodman. Neoplasms of the liver , 2007, Modern Pathology.
[13] C. Croce,et al. Cyclin G 1 Is a Target of miR-122 a , a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma , 2007 .
[14] Laura Mariani,et al. MicroRNAs modulate the angiogenic properties of HUVECs. , 2006, Blood.
[15] M. Rattray,et al. A tumor progression model for hepatocellular carcinoma: bioinformatic analysis of genomic data. , 2006, Gastroenterology.
[16] Oliver Hobert,et al. Perfect seed pairing is not a generally reliable predictor for miRNA-target interactions , 2006, Nature Structural &Molecular Biology.
[17] Y. Jeng,et al. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma , 2006, The Journal of pathology.
[18] X. Agirre,et al. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues , 2006, Molecular Cancer.
[19] Kristoffer Brännström,et al. Aneugenic activity of Op18/stathmin is potentiated by the somatic Q18-->e mutation in leukemic cells. , 2006, Molecular biology of the cell.
[20] C. Benz,et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies , 2006, Molecular Cancer.
[21] Tushar Patel,et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. , 2006, Gastroenterology.
[22] N. Rajewsky. microRNA target predictions in animals , 2006, Nature Genetics.
[23] T. Okanoue,et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues , 2006, Oncogene.
[24] R. Stephens,et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.
[25] N. Rajewsky,et al. Cell-type-specific signatures of microRNAs on target mRNA expression. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[26] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[27] J. Bruix,et al. Treatment of hepatocellular carcinoma , 1997, Critical reviews in oncology/hematology.
[28] C. Croce,et al. The role of microRNA genes in papillary thyroid carcinoma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[29] Alessandro Fatica,et al. A Minicircuitry Comprised of MicroRNA-223 and Transcription Factors NFI-A and C/EBPα Regulates Human Granulopoiesis , 2005, Cell.
[30] Muller Fabbri,et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.
[31] C. Croce,et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[32] C. Croce,et al. MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.
[33] K. Kosik,et al. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. , 2005, Cancer research.
[34] Yong Zhao,et al. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis , 2005, Nature.
[35] J. Squire,et al. Transcriptional profiling on chromosome 19p indicated frequent downregulation of ACP5 expression in hepatocellular carcinoma , 2005, International journal of cancer.
[36] F. X. Bosch,et al. Epidemiology of hepatocellular carcinoma. , 2005, Clinics in liver disease.
[37] J. Squire,et al. Transcriptional profiling identifies gene expression changes associated with IFN-alpha tolerance in hepatitis C-related hepatocellular carcinoma cells. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[38] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[39] G. Atweh,et al. The role of stathmin in the regulation of the cell cycle , 2004, Journal of cellular biochemistry.
[40] C. Croce,et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[41] S. Fan,et al. Clinicopathologic significance of genetic alterations in hepatocellular carcinoma. , 2003, Cancer genetics and cytogenetics.
[42] Michael Z Michael,et al. Reduced accumulation of specific microRNAs in colorectal neoplasia. , 2003, Molecular cancer research : MCR.
[43] V. Ambros,et al. MicroRNA Pathways in Flies and Worms Growth, Death, Fat, Stress, and Timing , 2003, Cell.
[44] J. Squire,et al. Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization. , 2003, Neoplasia.
[45] W. Lau,et al. Consistent chromosome 10 rearrangements in four newly established human hepatocellular carcinoma cell lines , 2002, Genes, chromosomes & cancer.
[46] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[47] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[48] S. Hanash,et al. Oncoprotein 18 levels and phosphorylation mediate megakaryocyte polyploidization in human erythroleukemia cells , 2001, Proteomics.
[49] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[50] K. Yeo,et al. Characterization of cell lines established from human hepatocellular carcinoma , 1995, International journal of cancer.
[51] G. Landberg,et al. Quantitative analysis of the expression and regulation of an activation-regulated phosphoprotein (oncoprotein 18) in normal and neoplastic cells. , 1993, Leukemia.
[52] H. Koyama,et al. Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma. , 1992, Surgery.
[53] J. Strahler,et al. Involvement of OP18 in cell proliferation. , 1991, Biochemical and biophysical research communications.
[54] F. Miglio,et al. [Epidemiology of hepatocellular carcinoma]. , 1991, Minerva gastroenterologica e dietologica.
[55] N. Okazaki,et al. Prognosis of Primary Hepatocellular Carcinoma , 1984, Hepatology.